Tang Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $958K | Hold |
126,655
| – | – | 0.05% | 157 |
|
|
2025
Q1 | $699K | Hold |
126,655
| – | – | 0.04% | 175 |
|
|
2024
Q4 | $728K | Hold |
126,655
| – | – | 0.05% | 166 |
|
|
2024
Q3 | $1.31M | Sell |
126,655
-173,345
| -58% | -$1.8M | 0.09% | 103 |
|
|
2024
Q2 | $3.89M | Hold |
300,000
| – | – | 0.4% | 67 |
|
|
2024
Q1 | $5.24M | Hold |
300,000
| – | – | 0.55% | 56 |
|
|
2023
Q4 | $2.82M | Buy |
+300,000
| New | +$2.82M | 0.26% | 80 |
|
|
2023
Q2 | – | Sell |
-90,000
| Closed | -$3.64M | – | 103 |
|
|
2023
Q1 | $3.64M | Sell |
90,000
-110,000
| -55% | -$4.45M | 0.54% | 48 |
|
|
2022
Q4 | $9.3M | Buy |
200,000
+62,300
| +45% | +$2.9M | 1.35% | 21 |
|
|
2022
Q3 | $7.14M | Hold |
137,700
| – | – | 0.88% | 36 |
|
|
2022
Q2 | $6.51M | Buy |
137,700
+37,700
| +38% | +$1.78M | 0.99% | 26 |
|
|
2022
Q1 | $7.12M | Buy |
+100,000
| New | +$7.12M | 1.42% | 22 |
|
|
2020
Q2 | – | Sell |
-13,483
| Closed | -$693K | – | 22 |
|
|
2020
Q1 | $693K | Buy |
+13,483
| New | +$693K | 0.1% | 21 |
|